HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Medicine / Faculty of Medicine >
Peer-reviewed Journal Articles, etc >

Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC)

Files in This Item:
FINAL_20140901_JCOG1212_JJCO_clinical_note.pdf304.16 kBPDFView/Open
Please use this identifier to cite or link to this item:http://hdl.handle.net/2115/59591

Title: Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC)
Authors: Homma, Akihiro Browse this author →KAKEN DB
Nakamura, Kenichi Browse this author
Matsuura, Kazuto Browse this author
Mizusawa, Junki Browse this author
Onimaru, Rikiya Browse this author →KAKEN DB
Fukuda, Haruhiko Browse this author
Fujii, Masato Browse this author →KAKEN DB
Keywords: maxillary sinus cancer
squamous cell carcinoma
chemoradiotherapy
intra-arterial
cisplatin
Issue Date: Jan-2015
Publisher: Oxford University Press
Journal Title: Japanese Journal Of Clinical Oncology
Volume: 45
Issue: 1
Start Page: 119
End Page: 122
Publisher DOI: 10.1093/jjco/hyu169
PMID: 25332419
Abstract: A dose-finding and efficacy confirmation trial was started in Japan in April 2014 to evaluate the efficacy and safety of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer. A total of 18 patients will be enrolled in the dose-finding phase for the determination of the recommended number of cisplatin cycles, and 65 patients with T4aN0M0 and 62 patients with T4bN0M0, including those who received the recommended number of or fewer cycles in the dose-finding phase, will be enrolled from 16 institutions within a 5-year period in the efficacy confirmation phase. The primary endpoints of the dose-finding and the efficacy confirmation phases are dose-limiting toxicities and 3-year overall survival, respectively. This trial was registered at the UMIN Clinical Trials Registry (http://www.umin.ac.jp/ctr/) under Trial No. UMIN000013706.
Rights: This is a pre-copyedited, author-produced PDF of an article accepted for publication in Japanese Journal of Clinical Oncology following peer review. The version of record "Dose-finding and efficacy confirmation trial of superselective intra-arterial infusion of cisplatin and concomitant radiotherapy for patients with locally advanced maxillary sinus cancer (JCOG1212, RADPLAT-MSC). Japanese Journal of Clinical Oncology. (2015) 45 (1): 119-122" is available online at: http://dx.doi.org/10.1093/jjco/hyu169
Type: article (author version)
URI: http://hdl.handle.net/2115/59591
Appears in Collections:医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 本間 明宏

Export metadata:


 

Feedback - Hokkaido University